M&As this week: Evotec, BioreclamationIVT
German pharmaceutical research company Evotec has acquired US-based drug discovery and development company Aptuit for $300m.
The acquisition will support Evotec’s long-term strategy to become a leader in drug discovery and development.
Biological products provider BioreclamationIVT has acquired biopharmaceutical company Asterand Bioscience.
The acquisition will enable BioreclamationIVT to expand its disease-state biospecimen capabilities.
Both companies involved in the acquisition are based in the US.